Skip to main content

University of Exeter Medical School

Dr Byron Creese

Dr Byron Creese

Senior Lecturer in Neuroscience

 RILD Building Level 4


University of Exeter Medical School, RILD Building, RD&E Hospital Wonford, Barrack Road, Exeter, EX2 5DW, UK


I am a translational and clinical researcher whose research focuses on neuropsychiatric symptoms in dementia and late-life onset neuropsychiatric symptoms as markers of neurodegenerative disease. My research utilizes a variety of approaches, including genomics, psychology and epidemiology, to investigate the disease mechanisms and clinical consequences of these symptoms.

One of my main areas of interest is chracterising psychosis in dementia and as an early clinical marker of neurodegenerative disease. To achieve this, I study human tissue and population-based samples to examine the underlying mechanisms of these symptoms.

I have published numerous research articles in peer-reviewed journals and presented research at national and international conferences. In addition to my research, I am actively involved in mentoring students and am committed to fostering the next generation of dementia researchers.

I received my PhD from King's College London and completed a postdoctoral research there and at University of Exeter.

Research group links

Back to top


Research interests

  • Psychosis and other neuropsychiatric symptoms in dementia, including biological mechanisms and treatments.
  • Neuropsychiatric symptoms as early indicators of neurodgenerative disease (known as Mild Behavioural Impairment)

Research projects

PROTECT study ( in UK and Canada (online studies into cognitive ageing).

A multi-omic approach to elucidating disease mechanisms of psychosis in Alzheimer’s disease. 

Elucidating the role of DNA methylation in the pathophysiology of lewy body diseases.

Research grants

  • 2019 National Institutes of Health
    A multi-omic approach to elucidating disease mechanisms of psychosis in Alzheimer’s disease
  • 2019 ARUK South West Network
    An examination of the neuropsychological mechanisms underpinning delusional thoughts in older adults at risk of dementia
  • 2019 ISSF Wellcome Trust Seed Corn Fund
    A preclinical drug screening protocol for the detection of off-target activity of psychotropic drugs for the treatment of neuropsychiatric symptoms in Alzheimer’s disease
  • 2019 MRC
    Elucidating the role of DNA methylation in the pathophysiology of lewy body diseases
  • 2018 MRC Proximity to Discovery
    Identifying genetic and clinical markers of cognitive decline in healthy adults
  • 2018 MRC Proximity to Discovery
    Mechanisms of therapeutic benefit and harm underpinning compounds used for treatment of neuropsychiatric symptoms in Alzheimer’s disease
  • 2018 ARUK South West Network
    Feasibility study of a proxy phenotype of psychotic symptoms in Alzheimer’s disease

Back to top

External Engagement and Impact


2019: Alzheimer’s Association ISTAART Neuropsychiatric Syndromes New Investigator Award.

Committee/panel activities

Executive Committee Member: Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) Neuropsychiatric Syndrome Professional Interest Area



Back to top


Cognitive neuroscience and neuropsychology with a particular focus on Alzheimer's disease and neuropsychiatric symptoms



Information not currently available

Back to top

Supervision / Group

Postgraduate researchers

Back to top

Edit Profile